School of Cancer and Pharmaceutical Sciences, King's College London, 150 Stamford Street, SE1 9NH, London, United Kingdom.
School of Cancer and Pharmaceutical Sciences, King's College London, 150 Stamford Street, SE1 9NH, London, United Kingdom.
Eur J Med Chem. 2021 Apr 15;216:113293. doi: 10.1016/j.ejmech.2021.113293. Epub 2021 Feb 13.
Compounds incorporating guanidine moieties constitute a versatile class of biologically interesting molecules with a wide array of applications. As such, guanidines have been exploited as privileged structural motifs in designing novel drugs for the treatment of various infectious and non-infectious diseases. In designing anti-infective agents, this moiety carries great appeal by virtue of attributes such as hydrogen-bonding capability and protonatability at physiological pH in the context of interaction with biological targets. This review provides an overview of recent advances in hit-to-lead development studies of antimicrobial guanidine-containing compounds with the aim to highlight their structural diversity and the pharmacological relevance of the moiety to drug activity, insofar as possible. In so doing, emphasis is put on chemical and microbiological properties of such compounds in relation to antibacterial, antifungal and antimalarial activities.
胍基化合物是一类具有广泛应用的生物活性分子,胍基作为一种优势结构模块,已被广泛应用于新型药物的设计,以治疗各种传染性和非传染性疾病。在设计抗感染药物时,由于胍基在与生物靶标相互作用时具有氢键形成能力和在生理 pH 值下质子化的特性,因此具有很大的吸引力。本综述概述了含胍基抗菌先导化合物的研发进展,重点介绍了其结构多样性和该结构模块对药物活性的药理学相关性。在讨论中,强调了此类化合物的化学和微生物学性质与其抗菌、抗真菌和抗疟活性的关系。